Evidence map›Paper›PMID 41440979›Full record

ReviewJournal of personalized medicine2025

Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes.

Mikhail Parshenkov, Sergey Zyryanov, Galina Rodionova, Anna Dyakonova, Petr Shegay, Andrei Kaprin, Grigory Demyashkin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. New Personalized Medicine Model for Medication Management.Journal of personalized medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mikhail ParshenkovDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky pass., 3, 125284 Moscow, Russia.ORCID 0009-0004-7170-8783
Sergey ZyryanovDepartment of General and Clinical Pharmacology, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya st., 6, 117198 Moscow, Russia.ORCID 0000-0002-6348-6867
Galina RodionovaDepartment of Pharmaceutical and Toxicological Chemistry Named After A.P. Arzamastsev, FSAEI HE I.M. Sechenov First MSMU of MOH of Russia (Sechenovskiy University), ave. Vernadsky, 96k1, 119526 Moscow, Russia.ORCID 0000-0002-0536-9590
Anna DyakonovaDepartment of Pharmaceutical and Toxicological Chemistry Named After A.P. Arzamastsev, FSAEI HE I.M. Sechenov First MSMU of MOH of Russia (Sechenovskiy University), ave. Vernadsky, 96k1, 119526 Moscow, Russia.ORCID 0009-0004-4520-192X
Petr ShegayDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky pass., 3, 125284 Moscow, Russia.
Andrei KaprinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky pass., 3, 125284 Moscow, Russia.
Grigory DemyashkinLaboratory of Histology and Immunohistochemistry, Institute of Translational Medicine and Biotechnology, FSAEI HE I.M. Sechenov First MSMU of MOH of Russia (Sechenovskiy University), Trubetskaya st., 8/2, 119048 Moscow, Russia.ORCID 0000-0001-8447-2600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial intelligencemajor depressive disorderpharmacogeneticspharmacologyprecision psychiatrytherapeutic drug monitoring

Identifiers

PMID41440979
PMCPMC12733439

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.